Pharmacy Joe

NOVEMBER 17, 2024

In this episode, I’ll discuss how to become a peer reviewer for a medical journal. Episode 975: 3 Steps to Become a Journal Peer Reviewer Subscribe on iTunes , Android , or Stitcher One common reason for a pharmacist to wish to become a peer reviewer for a journal is to satisfy ASHP standards for preceptors in the area of ongoing professionalism. Additionally, being a peer reviewer helps uphold the scientific process, supports your favorite journal, and helps establish professional relationships

Hospitals 52

Hospitals Inpatient 52

Pharmacy Times

NOVEMBER 17, 2024

Rebekah Walker, PhD raises awareness of the long-lasting health implications caused by historic redlining.

55

55

PharmExec

NOVEMBER 17, 2024

Artificial intelligence (AI) can improve risk assessment and decision-making in drug development by applying objective, data-driven criteria consistently. Companies should focus on the quality of data, selecting the right AI use cases, and leveraging external partners to maximize the potential of AI.

Drug Development 52

Drug Development 52

Pharmacy Times

NOVEMBER 17, 2024

Leonard Egede, MD, MS, FACP discussed the association of historical redlining and contemporary structural racism on life expectancy.

52

52

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Express Pharma

NOVEMBER 17, 2024

The diagnosed prevalent cases of Parkinson’s disease (PD) in the seven major markets (7MM*) are projected to increase from 2.64 million in 2023 to 3.15 million in 2033, with an annual growth rate (AGR) of 1.94 per cent, according to GlobalData. GlobalData’s latest report, “Parkinson’s Disease Epidemiology Analysis and Forecast to 2033,” reveals that in 2033, the US is predicted to have the highest number of diagnosed prevalent cases of PD in the 7MM at 1.24 million, whereas Italy, with nearly 0.

105

105

Pharmacy Times

NOVEMBER 17, 2024

Value-based payment models are becoming increasingly common, leading clinicians to find novel ways to engage patients and improve disease control with the goal of reducing morbidity, mortality, and cost.

51

51

Pharmacy Times

NOVEMBER 17, 2024

Christian Ruff, MD, MPH shared the results of the AZALEA-TIMI 71 trial.

26

26

Express Pharma

NOVEMBER 17, 2024

Granules India has announced the appointment of Ovais Sarmad as an Advisor to the company. In this role, Sarmad will provide guidance on sustainability, climate policy, and environmental initiatives, supporting Granules’ efforts to incorporate sustainability into its operations. Sarmad brings over three decades of experience in global climate policy and sustainable development.

104

104

Pharmacy Times

NOVEMBER 17, 2024

Twice-yearly dosing could significantly improve adherence rates.

26

26

FDA Law Blog: Biosimilars

NOVEMBER 17, 2024

By JP Ellison — The word unprecedented has been used a lot in the past two weeks. Perhaps appropriately. Below is some precedent that’s been on this blogger’s mind recently and that may be relevant in the coming days, weeks, and months: Tummino v. Hamburg. Why? The HHS Secretary intervened in an FDA approval decision. The court ruled the agency’s action was arbitrary and capricious and entered a mandatory injunction ordering FDA to make the drug available.

64

64

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication